The Hindu Business Line : Turkey nod for GVK Bio unit

The clinical pharmacology unit of GVK Biosciences here has received approval from the Ministry of Health, Turkey, for conducting bioequivalence studies. A team of officials from Turkey inspected the facility and carried out a detailed audit of systems and processes for Good Clinical Practices and Good Laboratory Practices requirements before granting approval, according to a release. The approval would enable the company to cater to generic drug manufacturers in Turkey as well as to those who intend to market their generic drug products in Turkey, the release said. - Our Bureau

More Stories on : Standards & Benchmarks | Bio-tech & Genetics

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Maytas Infra board meets today

Strides plants get US cGMP tag

Coromandel Fert additional director

IOC eyes overseas funds for Paradip project

ICSA bags Rs 464-cr orders

BEML to sell French firm’s tunnel boring machines

H&R Johnson in pact with Gujarat co

MRPL help for water supply

Turkey nod for GVK Bio unit

Delphi sees ‘huge potential’ for engine management system

KIOCL likely to post loss in Q4

German co Wirtgen plans facility in Pune

Bhilai Steel Plant stepping up railway facilities to meet demand